Research
Exploring life science and new possibilities for medicine through basic and applied research.
CSI Global Health, Co., Ltd. Okayama University-based Start Up 
CSI GLOBAL HEALTH / THE FUTURE OF LIFE
From one particle to a healthier world.
Bringing precision medicine together with the wisdom of life
to explore a future of health, longevity and wellbeing.
Research foundations at Okayama University / Medical innovation for the world
Exploring life science and new possibilities for medicine through basic and applied research.
Exploring research and technologies related to boron neutron capture therapy (BNCT).
Considering ways to connect discoveries in basic research with clinical applications.
Expanding possibilities through dialogue with researchers and specialists around the world.
Connecting research and technology to contribute to the future of health and medicine.
OUR PHILOSOPHY
Life is an intricate symphony of particles, molecules, cells and ecosystems. Grounded in research and guided by patients' needs, CSI connects medicine, pharmaceutical sciences, physics, engineering and digital science to bring laboratory discoveries to real health challenges.
In the age of AI, we deepen our understanding of life through data, test hypotheses through experiments, and pursue the practical application of research through collaboration across disciplines. With human warmth at the heart of our work, we share the goal of contributing to longer, higher-quality lives.
A venture originating from Okayama University
CSI Global Health Co., Ltd.
From academic knowledge accumulated on campus to practical work at an entrepreneurial hub, CSI brings together researchers, engineering and industry to expand the possibilities of life sciences through rigorous research and open collaboration.

Exploring possibilities in life sciences and medicine from a foundation in university research.

Exploring research across disciplines, grounded in university research. Photo: Faculty of Science, Okayama University.

Based in the Okayama University incubator, connecting research and business.

Corridors and meeting spaces support daily work and research exchange.
Connecting medicines, imaging, equipment and people around BNCT. We explore precision particle medicine with practical application in view.

Exploring research that connects medicines, neutron sources and biological evaluation around boron neutron capture therapy.

Studying tumor accumulation and cellular uptake through boron clusters and nanoscale delivery systems.

Exploring evaluation methods that trace drug distribution and connect diagnostic and therapeutic research.

Exploring compact equipment, shielding design and stable neutron generation for research applications.

Exploring technologies that support medical research equipment through advanced materials and power electronics.

Exploring international research collaboration and pathways to bring research outcomes into clinical and social use.
CSI GLOBAL HEALTH
CSI Global Health Co., Ltd.
From academic knowledge accumulated on campus to practical work at an entrepreneurial hub, CSI brings together researchers, engineering and industry to expand the possibilities of life sciences through rigorous research and open collaboration.
Dr Eiji Matsuura's work, grounded in immunology and biochemistry, includes molecular imaging, targeted medicine, BNCT drug delivery systems (DDS), and theranostics. CSI explores pathways for connecting such research findings with clinical applications and medical technology.

FOUNDER & CEO
Founder & CEO · Professor Emeritus, Okayama University
At CSI Global Health, we seek to connect scientific research with clinical translation and international collaboration. Building on a research foundation related to Okayama University, we will continue to foster practical dialogue across medicine, technology and industry, from Japan to the world.
External expertise informs the evaluation of research and business direction.

Pharmacy and drug discovery
His work includes Alzheimer’s disease research; his profile identifies him as a developer of the Alzheimer’s medicine Aricept.

BNCT specialist
Professor Emeritus at the University of Duisburg-Essen and Visiting Professor at Okayama University’s Neutron Therapy Research Center. His work includes early European clinical BNCT.

Immunotherapy and drug discovery
Professor at the University of Strasbourg and Emeritus Research Director at CNRS. Her work focuses on immunotherapy and innovative drug discovery.

BNCT and nanomedicine
Associate Professor at Loma Linda University. His research includes BNCT, drug delivery, nanomedicine, the blood–brain barrier and brain tumors.
BNCT-related patents
Listed as an inventor on BNCT-related patents in J-GLOBAL.
BioMedica Diagnostics Inc. / General Manager
Previously worked in clinical affairs and key account management at Verum Diagnostica. He co-authored a paper on thromboelastography (TEG) in transfusion management for trauma patients.
Corgenix Medical Corporation / Former CEO & Chairman
Served as CEO and Chairman from 1998 to 2006, then as Chief Medical Officer; stepped down as Chairman in 2009.
Research on boron agents and DDS benefits from collaboration across drug distribution, molecular imaging and quantitative evaluation. Through equipment briefings by Professor Matsuura, facility visits and team discussions, we share an understanding of research methods and evaluation pathways.
RESEARCHER VOICE / SHIMADZU FEATURE
Shimadzu's Boomerang Vol. 43 features Professor Eiji Matsuura's work in molecular imaging and drug delivery, and its potential applications in medicine.
Research scenes: facility visits, equipment briefings and team exchange.
DIGITAL SCIENCE & AI

DISCOVER
Explore AI-assisted boron drug design and candidate selection, developing testable hypotheses through computation and refining models through experiments.
UNDERSTAND
Combine molecular imaging with quantitative data to deepen understanding of distribution, uptake and change over time in tissues and cells.
CONNECT
Bring medicines, beams, materials and biological effects together through standardised data and collaboration, while exploring traceable research evaluation.
Digital science and AI represent a future research vision. Specific activities will be considered through ongoing validation.

GLOBAL COLLABORATION
With Japan as a starting point for research, we envision dialogue with researchers and industry across regions including China, the United States and Europe. Through exchange around shared scientific questions, we will explore possibilities for collaboration across disciplines and regions.
NEWS & MEDIA / INTERNATIONAL EXCHANGE
A record of international exchange and research collaboration
Around life sciences, BNCT and medical innovation, Professor Eiji Matsuura has built academic, technical and industry exchange with specialists in the United States, Germany, France, China and other regions, extending dialogue between research and application.
From research facility visits and expert discussions to dialogue on translating research outcomes, these nine photographs introduce exchanges that share knowledge across disciplines.

Group photo at an international academic exchange

Exchange and dialogue with researchers

Research facility visit and technical exchange

Dialogue on academic and business collaboration

Discussion among specialists

Visit and exchange toward research collaboration

Conversation with international researchers

Academic and research collaboration meeting

Group photo of academic exchange participants